References
- Arai M., Serizawa N., Terahara A., Tsujita Y., Tanaka M., Masuda H., Ishikawa S. Pravastatin sodium (CS-514), a novel cholesterol-lowering agent which inhibits HMG-CoA reductase. Annual Reports of Sankyo Research Laboratories 1988; 40: 1–38
- Hammarström S., Murphy R. C., Samuelsson B., Clark D. A., Mioskowski C., Corey E. J. Structure of leucotriene C, identification of the amino acid part. Biochemical and Biophysical Research Communications 1979; 91: 1266–1272
- Haruyama H., Kuwano H., Kinoshita T., Terahara A., Nishigaki T., Tamura C. Structure elucidation of the bioactive metabolites of ML-236B (mevastatin) isolated from dog urine. Chemical and Pharmaceutical Bulletin 1986; 34: 1459–1467
- Hirota T., Nishikawa Y., Takahagi H., Igarashi T., Kitagawa H. Simultaneous purification and properties of dehydropeptidase-I and aminopeptidase-M from rat kidney. Research Communications in Chemical Pathology and Pharmacology 1985; 49: 435–445
- Komai T., Kawai K., Shigehar A. E., Kuroiwa C., Kawasaki Y., Kitazawa E., Tanaka M. Metabolic study of pravastatin sodium(I), Metabolism and disposition of 14C-pravastatin in experimental animals. Second International ISSX Meeting,KobeJapan,May, 16–201988
- Molbéus P., Hoegberg I., Orrenius S. Isolation and use of liver cells. Methods in Enzymology 1978; 52: 60–71
- Nakamura T., Yoda K., Kuwano H., Miyaguchi K., Muramatsu S., Takahagi H., Kinoshita T. Metabolism of pravastatin sodium in isolated rat hepatocytes. II. Structure elucidation of the metabolites by n.m.r. spectroscopy. Xenobiotica 1991; 21: 277–293
- Tsujita Y., Kuroda M., Shimada Y., Tanzawa K., Arai M., Kaneko I., Tanaka M., Masuda H., Tarumi C., Watanabe Y., Fujii S. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypo-lipidemic effect on various animal species. Biochimica et Biophysica Acta 1986; 877: 50–60